ID   FIBB_RAT                Reviewed;         479 AA.
AC   P14480; Q5I0P7; Q7TME5;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   29-MAY-2024, entry version 176.
DE   RecName: Full=Fibrinogen beta chain;
DE   AltName: Full=Liver regeneration-related protein LRRG036/LRRG043/LRRG189;
DE   Contains:
DE     RecName: Full=Fibrinopeptide B;
DE   Contains:
DE     RecName: Full=Fibrinogen beta chain;
DE   Flags: Precursor;
GN   Name=Fgb; ORFNames=Ab1-181, Ab1-216, Ac1-581;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=7841303;
RA   Courtney M.A., Bunce L.A., Neroni L.A., Simpson-Haidaris P.J.;
RT   "Cloning of the complete coding sequence of rat fibrinogen B beta chain
RT   cDNA: interspecies conservation of fibrin beta 15-42 primary structure.";
RL   Blood Coagul. Fibrinolysis 5:487-496(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Xu C.S., Li W.Q., Li Y.C., Chang C.F., Chai L.Q., Yuan J.Y., Yang K.J.,
RA   Yan H.M., Zhao L.F., Ma H., Wang L., Wang S.F., Han H.P., Wang G.P.,
RA   Shi J.B., Rahman S., Wang Q.N., Zhang J.B.;
RT   "Liver regeneration after PH.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-26.
RX   PubMed=6232608; DOI=10.1073/pnas.81.8.2313;
RA   Fowlkes D.M., Mullis N.T., Comeau C.M., Crabtree G.R.;
RT   "Potential basis for regulation of the coordinately expressed fibrinogen
RT   genes: homology in the 5' flanking regions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:2313-2316(1984).
RN   [5]
RP   PROTEIN SEQUENCE OF 19-32 (ISOFORM 1).
RA   Blombaeck B., Blombaeck M., Grondahl N.J.;
RT   "Studies on fibrinopeptides from mammals.";
RL   Acta Chem. Scand. 19:1789-1791(1965).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 183-479 (ISOFORMS 1/2).
RX   PubMed=2673932; DOI=10.1016/0378-1119(89)90100-5;
RA   Eastman E.M., Gilula N.B.;
RT   "Cloning and characterization of a cDNA for the B beta chain of rat
RT   fibrinogen: evolutionary conservation of translated and 3'-untranslated
RT   sequences.";
RL   Gene 79:151-158(1989).
RN   [7]
RP   PROTEIN SEQUENCE OF 151-167; 235-255 AND 415-424 (ISOFORMS 1/2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (DEC-2006) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 425-479 (ISOFORM 1).
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=3817019; DOI=10.1016/0014-4827(87)90223-0;
RA   Sobczak J., Lotti A.-M., Taroux P., Duguet M.;
RT   "Molecular cloning of mRNA sequences transiently induced during rat liver
RT   regeneration.";
RL   Exp. Cell Res. 169:47-56(1987).
CC   -!- FUNCTION: Cleaved by the protease thrombin to yield monomers which,
CC       together with fibrinogen alpha (FGA) and fibrinogen gamma (FGG),
CC       polymerize to form an insoluble fibrin matrix. Fibrin has a major
CC       function in hemostasis as one of the primary components of blood clots.
CC       In addition, functions during the early stages of wound repair to
CC       stabilize the lesion and guide cell migration during re-
CC       epithelialization. Was originally thought to be essential for platelet
CC       aggregation, based on in vitro studies using anticoagulated blood.
CC       However subsequent studies have shown that it is not absolutely
CC       required for thrombus formation in vivo. Enhances expression of SELP in
CC       activated platelets. Maternal fibrinogen is essential for successful
CC       pregnancy. Fibrin deposition is also associated with infection, where
CC       it protects against IFNG-mediated hemorrhage. May also facilitate the
CC       antibacterial immune response via both innate and T-cell mediated
CC       pathways. {ECO:0000250|UniProtKB:E9PV24}.
CC   -!- SUBUNIT: Heterohexamer; disulfide linked. Contains 2 sets of 3 non-
CC       identical chains (alpha, beta and gamma). The 2 heterotrimers are in
CC       head to head conformation with the N-termini in a small central domain
CC       (By similarity). {ECO:0000250|UniProtKB:P02675}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P14480-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P14480-2; Sequence=VSP_022492, VSP_022493;
CC   -!- DOMAIN: A long coiled coil structure formed by 3 polypeptide chains
CC       connects the central nodule to the C-terminal domains (distal nodules).
CC       The long C-terminal ends of the alpha chains fold back, contributing a
CC       fourth strand to the coiled coil structure.
CC       {ECO:0000250|UniProtKB:P02675}.
CC   -!- PTM: Conversion of fibrinogen to fibrin is triggered by thrombin, which
CC       cleaves fibrinopeptides A and B from alpha and beta chains, and thus
CC       exposes the N-terminal polymerization sites responsible for the
CC       formation of the soft clot.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U05675; AAA64866.1; -; mRNA.
DR   EMBL; AY321323; AAP86255.1; -; mRNA.
DR   EMBL; AY325147; AAP92548.1; -; mRNA.
DR   EMBL; AY325153; AAP92554.1; -; mRNA.
DR   EMBL; BC088102; AAH88102.1; -; mRNA.
DR   EMBL; K01336; AAA98625.1; -; Genomic_DNA.
DR   EMBL; M27220; AAA41160.1; -; mRNA.
DR   EMBL; M35602; AAA41159.1; -; mRNA.
DR   PIR; A05299; A05299.
DR   PIR; I67595; I67595.
DR   RefSeq; NP_064456.2; NM_020071.2. [P14480-1]
DR   AlphaFoldDB; P14480; -.
DR   SMR; P14480; -.
DR   IntAct; P14480; 2.
DR   STRING; 10116.ENSRNOP00000009813; -.
DR   GlyCosmos; P14480; 1 site, No reported glycans.
DR   GlyGen; P14480; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; P14480; -.
DR   PhosphoSitePlus; P14480; -.
DR   PaxDb; 10116-ENSRNOP00000050663; -.
DR   Ensembl; ENSRNOT00000040708.5; ENSRNOP00000050663.1; ENSRNOG00000007092.8. [P14480-2]
DR   GeneID; 24366; -.
DR   KEGG; rno:24366; -.
DR   UCSC; RGD:2604; rat. [P14480-1]
DR   AGR; RGD:2604; -.
DR   CTD; 2244; -.
DR   RGD; 2604; Fgb.
DR   VEuPathDB; HostDB:ENSRNOG00000007092; -.
DR   eggNOG; KOG2579; Eukaryota.
DR   GeneTree; ENSGT00940000158122; -.
DR   HOGENOM; CLU_038628_13_0_1; -.
DR   InParanoid; P14480; -.
DR   OMA; CIHADPD; -.
DR   OrthoDB; 3134470at2759; -.
DR   TreeFam; TF336658; -.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-140875; Common Pathway of Fibrin Clot Formation.
DR   Reactome; R-RNO-216083; Integrin cell surface interactions.
DR   Reactome; R-RNO-354192; Integrin signaling.
DR   Reactome; R-RNO-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-RNO-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-RNO-5674135; MAP2K and MAPK activation.
DR   Reactome; R-RNO-5686938; Regulation of TLR by endogenous ligand.
DR   PRO; PR:P14480; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000007092; Expressed in liver and 17 other cell types or tissues.
DR   GO; GO:0072562; C:blood microparticle; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0005577; C:fibrinogen complex; ISO:RGD.
DR   GO; GO:0031091; C:platelet alpha granule; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IEA:Ensembl.
DR   GO; GO:0051087; F:protein-folding chaperone binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:Ensembl.
DR   GO; GO:0005198; F:structural molecule activity; ISO:RGD.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0072378; P:blood coagulation, fibrin clot formation; ISO:RGD.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0044320; P:cellular response to leptin stimulus; IEP:RGD.
DR   GO; GO:0042730; P:fibrinolysis; ISO:RGD.
DR   GO; GO:0043152; P:induction of bacterial agglutination; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; ISO:RGD.
DR   GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; ISO:RGD.
DR   GO; GO:0031639; P:plasminogen activation; ISO:RGD.
DR   GO; GO:0070527; P:platelet aggregation; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0045921; P:positive regulation of exocytosis; ISO:RGD.
DR   GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:0090277; P:positive regulation of peptide hormone secretion; ISO:RGD.
DR   GO; GO:0050714; P:positive regulation of protein secretion; ISO:RGD.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; ISO:RGD.
DR   GO; GO:0051258; P:protein polymerization; ISO:RGD.
DR   GO; GO:0065003; P:protein-containing complex assembly; ISO:RGD.
DR   GO; GO:0051592; P:response to calcium ion; ISO:RGD.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 1.20.5.50; -; 2.
DR   Gene3D; 3.90.215.10; Gamma Fibrinogen, chain A, domain 1; 1.
DR   InterPro; IPR037579; Fibrinogen.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR012290; Fibrinogen_a/b/g_coil_dom.
DR   InterPro; IPR020837; Fibrinogen_CS.
DR   NCBIfam; NF040941; GGGWT_bact; 1.
DR   PANTHER; PTHR47221; FIBRINOGEN ALPHA CHAIN; 1.
DR   PANTHER; PTHR47221:SF2; FIBRINOGEN BETA CHAIN; 1.
DR   Pfam; PF08702; Fib_alpha; 1.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SMART; SM01212; Fib_alpha; 1.
DR   SUPFAM; SSF56496; Fibrinogen C-terminal domain-like; 1.
DR   SUPFAM; SSF58010; Fibrinogen coiled-coil and central regions; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Alternative splicing; Blood coagulation; Coiled coil;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Hemostasis;
KW   Immunity; Innate immunity; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..18
FT   PEPTIDE         19..32
FT                   /note="Fibrinopeptide B"
FT                   /id="PRO_0000009086"
FT   CHAIN           33..479
FT                   /note="Fibrinogen beta chain"
FT                   /id="PRO_0000009085"
FT   DOMAIN          220..476
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   REGION          20..82
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          33..35
FT                   /note="Beta-chain polymerization, binding distal domain of
FT                   another fibrin"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        27..46
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        65..82
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            32..33
FT                   /note="Cleavage; by thrombin; to release fibrinopeptide B"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        382
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        211
FT                   /note="Interchain (with alpha chain)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        215
FT                   /note="Interchain (with gamma chain)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        219..304
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        229..258
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        412..425
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   VAR_SEQ         1..26
FT                   /note="MRHLWLLLLSVSLVQTQAATTDSDKV -> MSVPTRDTVITIHELVPNSSNS
FT                   KRK (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_022492"
FT   VAR_SEQ         463..479
FT                   /note="YSMRRMSMKIRPVFPQQ -> TPRQHLLLQRVPPQGSSVVMATCLHGTKCPE
FT                   SQLLDVHLNED (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_022493"
FT   CONFLICT        28..30
FT                   /note="LSI -> ILS (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        95
FT                   /note="P -> A (in Ref. 1; AAA64866)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        126
FT                   /note="S -> Y (in Ref. 1; AAA64866)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        197
FT                   /note="I -> M (in Ref. 1; AAA64866 and 6; AAA41160)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        439
FT                   /note="L -> Q (in Ref. 8; AAA41159)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        441
FT                   /note="S -> T (in Ref. 8; AAA41159)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        445
FT                   /note="S -> A (in Ref. 8; AAA41159)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        467
FT                   /note="R -> K (in Ref. 8; AAA41159)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        475
FT                   /note="V -> F (in Ref. 8; AAA41159)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   479 AA;  54235 MW;  810698D9A65D0DE7 CRC64;
     MRHLWLLLLS VSLVQTQAAT TDSDKVDLSI ARGHRPVDRR KEEPPSLRPA PPPISGGGYR
     ARPAKVDAGQ KKVERKPPDA GGCVHGDGDM GVLCPTGCEL RQTLLNHERP IKNSIAELNS
     NINSVSETSS VTFQYLTLLK DMWKKKQAQV KDNENVINEY SSILEDQKLY IDETVNDNIP
     LNLRVLRSIL EDLRSKIQKL ESDISAQTEY CHTPCTVNCN IPVVSGKECE EIIRKGGETS
     EMYLIQPDTS SKPYRVYCDM KTENGGWTVI QNRQDGSVDF GRKWDPYKKG FGNIATNEDT
     KKYCGLPGEY WLGNDKISQL TRIGPTELLI EMEDWKGDKV KAHYGGFTVQ TEANKYQVSV
     NKYKGTAGNA LMEGASQLVG ENRTMTIHNG MFFSTYDRDN DGWVTTDPRK QCSKEDGGGW
     WYNRCHAANP NGRYYWGGLY SWDMSKHGTD DGVVWMNWKG SWYSMRRMSM KIRPVFPQQ
//
